Thema: US58933Y1055
Merck & Co., US58933Y1055
Merck US58933Y1055 Onkologie-Labor: Wissenschaftler am Mikroskop analysiert Krebszellen, mehrere Wirkstoff-Vials stehen auf der Werkbank - Foto: THN
Merck & Co. stock lifts outlook as Q3 sales reach USD 18.1 billion
Merck & Co. stock faces a stronger earnings outlook after the company lifted its 2026 adjusted EPS range. Pipeline milestones add support.
ad-hoc-news.de, heute 11:39 Uhr
Merck & Co., US58933Y1055
Merck & Co. stock: Q3 sales and pipeline strengthen outlook ...
Merck & Co. stock enters the weekend after stronger third-quarter sales and a higher 2026 outlook. Pipeline data add another catalyst.
ad-hoc-news.de, 31.10.26 10:09 Uhr
Merck & Co., US58933Y1055
Merck & Co. stock: Q3 sales beat raises 2026 outlook
Merck & Co. stock enters Friday trading after stronger third-quarter sales. The company raised its adjusted 2026 earnings outlook.
ad-hoc-news.de, 30.10.26 16:47 Uhr
Merck & Co., US58933Y1055
Merck & Co. stock: Q3 sales beat as 2026 outlook rises
Merck & Co. stock enters Friday trading after stronger third-quarter sales and a higher 2026 adjusted earnings outlook. KEYTRUDA led oncology growth.
ad-hoc-news.de, 30.10.26 11:59 Uhr
Merck & Co., US58933Y1055
Merck & Co. stock jumps as Q3 sales beat and outlook rises ...
Merck & Co. stock gains after third-quarter sales reached USD 18.1 billion. The company raised its full-year adjusted profit outlook.
ad-hoc-news.de, 29.10.26 17:51 Uhr
Merck & Co., US58933Y1055
Merck presents sac-TMT results. Merck & Co. stock gains ...
TroFuse-005 cut death risk 32.00 percent on October 26, 2026. Merck & Co. stock costs EUR 128.60, 1.93 percent above the Xetra close.
ad-hoc-news.de, 29.10.26 11:31 Uhr
Merck & Co., US58933Y1055
HSBC raises target for Merck & Co. stock to USD 175.00
Merck reports third-quarter results October 29, 2026. Merck & Co. stock costs EUR 127.87 on October 27, 2026, up 0.20 percent versus Xetra's close.
ad-hoc-news.de, 27.10.26 17:13 Uhr
Merck & Co., US58933Y1055
Barclays raises target for Merck & Co. stock from USD 150.00 ...
Q2 revenue hit USD 16.61 billion, up 5.10 percent year over year. Merck & Co. stock costs EUR 126.26 on October 27, 2026, below the EUR 126.36 Xetra close.
ad-hoc-news.de, 27.10.26 12:07 Uhr
Merck & Co., US58933Y1055
MarketScreener puts a USD 159.76 target on Merck & Co. stock ...
Q2 revenue reached USD 16.61 billion, up 1.97 percent. Merck & Co. stock costs EUR 126.29 on October 26, 2026, down 2.27 percent versus Xetra close.
ad-hoc-news.de, 26.10.26 17:40 Uhr
Merck & Co., US58933Y1055
HSBC raises Merck & Co. stock target to USD 175.00
